Decision

, 2008 FC 840 (Atomoxetine*)

Proth. Aalto - 2008-07-04

Read full decision. Automatically generated summary:

Are there circumstances in which a statement of claim should be allowed to be issued against a known corporation, but identified only as Company "X", involving a known patent but identified only as the "X" Patent and a known drug but identified only as the "X" drug? That, essentially, is the issue raised in this case. There does not appear to have been any prior cases in this court that have proceeded on this basis.

Decision relates to:

  • T-811-08 - NOVOPHARM LIMITED v. ELI LILLY AND COMPANY

 

Canadian Intellectual Property